Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67

被引：0
|
作者：
Rapoport, Bernardo Leon [1 ]
Barnard-Tidy, Jacqui [1 ]
van Eeden, Ronwyn [1 ]
Smit, Teresa [1 ]
Nayler, Simon [2 ]
Benn, Carol [3 ]
机构：
[1] Med Oncol Ctr Rosebank, Johannesburg, South Africa
[2] Gritzman & Thatcher Inc, Johannesburg, South Africa
[3] Netcare Breast Care Ctr, Johannesburg, South Africa
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P2-16-20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-16-20
引用
收藏
页数：2
相关论文
共 50 条
  • [41] P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
    Pan, Yunbao
    Yuan, Yufen
    Liu, Guoshi
    Wei, Yongchang
    [J]. PLOS ONE, 2017, 12 (02):
  • [42] Predictive and prognostic value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
    Wang, R-X
    Chen, S.
    Jin, X.
    Shao, Z-M
    [J]. CANCER RESEARCH, 2017, 77
  • [43] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Peter A Fasching
    Katharina Heusinger
    Lothar Haeberle
    Melitta Niklos
    Alexander Hein
    Christian M Bayer
    Claudia Rauh
    Ruediger Schulz-Wendtland
    Mayada R Bani
    Michael Schrauder
    Laura Kahmann
    Michael P Lux
    Johanna D Strehl
    Arndt Hartmann
    Arno Dimmler
    Matthias W Beckmann
    David L Wachter
    [J]. BMC Cancer, 11
  • [44] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    [J]. BMC CANCER, 2011, 11
  • [45] Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
    Munzone, Elisabetta
    Botteri, E.
    Sciandivasci, A.
    Curigliano, G.
    Nole, F.
    Mastropasqua, M.
    Rotmensz, N.
    Colleoni, M.
    Esposito, A.
    Adamoli, L.
    Luini, A.
    Goldhirsch, A.
    Viale, G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 277 - 282
  • [46] Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
    Elisabetta Munzone
    E. Botteri
    A. Sciandivasci
    G. Curigliano
    F. Nolè
    M. Mastropasqua
    N. Rotmensz
    M. Colleoni
    A. Esposito
    L. Adamoli
    A. Luini
    A. Goldhirsch
    G. Viale
    [J]. Breast Cancer Research and Treatment, 2012, 134 : 277 - 282
  • [47] Ki-67 expression in residual triple-negative breast tumors after neoadjuvant chemotherapy to predict for recurrence-free survival
    Pinto, Joseph A.
    Doimi, Franco F.
    Balko, Justin M.
    Arteaga, Carlos L.
    Gomez, Henry L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [48] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Chen, Rui
    Ye, Yin
    Yang, Chengcheng
    Peng, Yang
    Zong, Beige
    Qu, Fanli
    Tang, Zhenrong
    Wang, Yihua
    Su, Xinliang
    Li, Hongyuan
    Yang, Guanglun
    Liu, Shengchun
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 35 - 43
  • [49] Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
    Rui Chen
    Yin Ye
    Chengcheng Yang
    Yang Peng
    Beige Zong
    Fanli Qu
    Zhenrong Tang
    Yihua Wang
    Xinliang Su
    Hongyuan Li
    Guanglun Yang
    Shengchun Liu
    [J]. Breast Cancer Research and Treatment, 2018, 170 : 35 - 43
  • [50] Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers
    Srivastava, Pooja
    Wang, Tiannan
    Clark, Beth Z.
    Yu, Jing
    Fine, Jeffrey L.
    Villatoro, Tatiana M.
    Carter, Gloria J.
    Brufsky, Adam M.
    Gorantla, Vikram C.
    Huggins-Puhalla, Shannon L.
    Emens, Leisha A.
    Basili, Thais
    da Silva, Edaise M.
    Reis-Filho, Jorge S.
    Bhargava, Rohit
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
12345